2-111784385-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 1P and 0B. PP2
The NM_022662.4(ANAPC1):c.4933G>A(p.Glu1645Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000197 in 152,050 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_022662.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ANAPC1 | NM_022662.4 | c.4933G>A | p.Glu1645Lys | missense_variant | 41/48 | ENST00000341068.8 | NP_073153.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ANAPC1 | ENST00000341068.8 | c.4933G>A | p.Glu1645Lys | missense_variant | 41/48 | 1 | NM_022662.4 | ENSP00000339109.3 | ||
ANAPC1 | ENST00000427997.5 | c.3535G>A | p.Glu1179Lys | missense_variant | 30/37 | 1 | ENSP00000396695.1 | |||
ANAPC1 | ENST00000643447.1 | n.-42G>A | upstream_gene_variant | ENSP00000494863.1 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152050Hom.: 0 Cov.: 28
GnomAD3 exomes AF: 0.0000678 AC: 17AN: 250782Hom.: 0 AF XY: 0.0000516 AC XY: 7AN XY: 135546
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.0000151 AC: 22AN: 1461592Hom.: 0 Cov.: 32 AF XY: 0.00000963 AC XY: 7AN XY: 727104
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152050Hom.: 0 Cov.: 28 AF XY: 0.0000269 AC XY: 2AN XY: 74250
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 12, 2023 | The c.4933G>A (p.E1645K) alteration is located in exon 41 (coding exon 40) of the ANAPC1 gene. This alteration results from a G to A substitution at nucleotide position 4933, causing the glutamic acid (E) at amino acid position 1645 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at